Ning, Zhiqiang
Shenzhen Chipscreen Biosciences Co.
2 papers on CoChat
Most cited papers
- Verified
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jiang, Z., Li, W., Hu, X., Zhang, Q., Sun, T., Cui, S., Wang, S., Ouyang, Q., Yin, Y., Geng, C., et al. (2019) · The Lancet Oncology
Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies
Cited by 270
- Verified
Reverse effect of chidamide on endocrine resistance in estrogen receptor-positive breast cancer
ZHOU, Y., WANG, Y., ZHANG, K., ZHU, J., & NING, Z. (2018) · Journal of Shenzhen University Science and Engineering
Estrogen and related hormone effectsAdvanced Breast Cancer Therapies
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free